Oral agent therapy in the treatment of type 2 diabetes.

Bibliographic Details
Main Authors: Feinglos, M, Bethel, M
Format: Conference item
Published: 1999
_version_ 1797094987681234944
author Feinglos, M
Bethel, M
author_facet Feinglos, M
Bethel, M
author_sort Feinglos, M
collection OXFORD
description
first_indexed 2024-03-07T04:21:34Z
format Conference item
id oxford-uuid:cb32c29b-6c18-4cd9-97d7-375d6020ac7d
institution University of Oxford
last_indexed 2024-03-07T04:21:34Z
publishDate 1999
record_format dspace
spelling oxford-uuid:cb32c29b-6c18-4cd9-97d7-375d6020ac7d2022-03-27T07:13:04ZOral agent therapy in the treatment of type 2 diabetes.Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:cb32c29b-6c18-4cd9-97d7-375d6020ac7dSymplectic Elements at Oxford1999Feinglos, MBethel, M
spellingShingle Feinglos, M
Bethel, M
Oral agent therapy in the treatment of type 2 diabetes.
title Oral agent therapy in the treatment of type 2 diabetes.
title_full Oral agent therapy in the treatment of type 2 diabetes.
title_fullStr Oral agent therapy in the treatment of type 2 diabetes.
title_full_unstemmed Oral agent therapy in the treatment of type 2 diabetes.
title_short Oral agent therapy in the treatment of type 2 diabetes.
title_sort oral agent therapy in the treatment of type 2 diabetes
work_keys_str_mv AT feinglosm oralagenttherapyinthetreatmentoftype2diabetes
AT bethelm oralagenttherapyinthetreatmentoftype2diabetes